OXBRIDGE RE HOLDINGS Ltd current report, 02 December 2019

Oxbridge Re Holdings Ltd - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Oxbridge Re Holdings Limited on December 2, 2019. The Company is a Cayman Islands-based insurance entity with ordinary shares and warrants listed on The Nasdaq Capital Market under the symbols OXBR and OXBRW, respectively.

Key Financial Metrics

Based on the Company's Form 10-Q for the quarter ended September 30, 2019, the following financial data is disclosed:

  • Total Shareholders' Equity (Book Value): Approximately $7,973,000.
  • Cash and Restricted Cash Equivalents: Approximately $8,100,000.
  • Shares Outstanding: 5,733,587 ordinary shares.
  • Book Value Per Share: Approximately $1.39 (basic and diluted).
  • Underwriting Losses: None reported for the recent hurricane season.
  • Catastrophe Exposure: No exposure to recent California wildfires or other global catastrophes.

The filing does not provide specific figures for revenue, net profit, operating margins, or debt levels for the reporting period.

Material Changes and Listing Status

On December 2, 2019, the Company received notice from Nasdaq regarding non-compliance with Listing Rule 5550(a)(2). The closing bid price of the Company's ordinary shares fell below the required minimum of $1.00 per share for 30 consecutive business days.

Outlook, Risks, and Management Commentary

Compliance Period: The Company has been granted an initial 180-day period, ending June 1, 2020, to regain compliance. Compliance can be achieved if the closing bid price remains at or above $1.00 for 10 consecutive business days.

Remediation Strategy: Management intends to actively monitor the bid price and consider available options, including a reverse stock split, to resolve the deficiency.

Delisting Risk: If compliance is not met by June 1, 2020, the Company may be eligible for an additional 180-day period, provided it meets other listing standards (such as market value of publicly held shares). Failure to cure the deficiency could result in delisting, subject to appeal.

Uncertainty: The Company explicitly states there can be no assurance that it will regain compliance or maintain other listing requirements.

Investor Verification Checklist

  • Verify the current closing bid price of OXBR to determine if the 10-day compliance threshold has been met.
  • Monitor for any announcements regarding a reverse stock split or other capital structure changes.
  • Review the Company's cash position relative to its operating expenses to assess liquidity sustainability.
  • Check for any subsequent Nasdaq correspondence regarding the extension of the compliance period or delisting notices.